Evidence map›Paper›PMID 23750742›Full record

Trial reportSubstance use & misuse2013

Training and fidelity monitoring of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia: the IMPACT Effectiveness Trial.

Hilary Connery, Shelly Greenfield, Viktoriya Livchits, Lana McGrady, Nickolette Patrick, Charmaine S Lastimoso, Jessica H Heney, Adrianne Katrina Nelson, Alan Shields, Yekaterina P Stepanova and 4 more

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Substance use & misuse, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00675961 (Effectiveness of Alcohol Interventions Among TB Patients in Tomsk Oblast, Russia), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00675961 nacompletednot on this map

Effectiveness of Alcohol Interventions Among TB Patients in Tomsk Oblast, Russia

TypeinterventionalSponsorBrigham and Women's HospitalRan2007 to 2011Enrolled400ConditionsTuberculosis, Alcohol Use DisordersArmsBrief Counseling Intervention (BCI), Naltrexone, BCI + Naltrexone, Treatment as Usual
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Hilary ConneryAlcohol and Drug Abuse Treatment Program, McLean Hospital, Belmont, Massachusetts 02478, USA. hconnery@mclean.harvard.edu
Shelly Greenfield
Viktoriya Livchits
Lana McGrady
Nickolette Patrick
Charmaine S Lastimoso
Jessica H Heney
Adrianne Katrina Nelson
Alan Shields
Yekaterina P Stepanova
Lidia Y Petrova
Oleg V Anastasov
Olga I Novoseltseva
Sonya S Shin
Brigham and Women's Hospital · USMcLean Hospital · USNortheastern University · USPartners In Health · USTennessee State University · US

Funding

Mentoring in Substance Abuse Treatment ResearchK24DA019855 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI GREENFIELD, SHELLY F. · 2005 to 2014
$1.8M
Effectiveness of Alcohol Interventions Among TB Patients in Tomsk, RussiaR01AA016318 · NIAAA · BRIGHAM AND WOMEN'S HOSPITAL · PI SHIN, SONYA S · 2006 to 2008
$1.1M
NIAAA NIH HHS R01 AA016318NIDA NIH HHS K24 DA019855
6 · The paper itself

Abstract

IMPACT (Integrated Management of Physician-Delivered Alcohol Care for Tuberculosis patients) is a randomized, controlled effectiveness trial based in Tomsk, Russia, that assesses the effect of oral naltrexone and brief behavioral counseling on tuberculosis outcomes and alcohol use in 200 patients. Tuberculosis physicians without addiction experience delivered interventions as part of routine care over a 6-month period, focusing on alcohol intake reduction to support successful tuberculosis treatment. We describe design, training, and fidelity monitoring using a Russian and American team of physicians, bilingual coders, and supervisors. Culturally appropriate adaptations, limitations, and implications for future trials are discussed. The clinical trial identification number is NCT00675961. Funding came from the National Institutes of Health and National Institute on Drug Abuse.

Indexed as

AlcoholismNaltrexoneTuberculosisGuideline AdherenceHumansNarcotic AntagonistsPhysiciansRussiaNaltrexoneNarcotic Antagonists

Identifiers

PMID23750742
PMCPMC4010131
OpenAlexW2128366651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.